T2 Biosystems Inc
F:3T2
T2 Biosystems Inc
F:3T2
Price:
1.348
EUR
-2.18%
Market Closed
Market Cap:
€407.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
T2 Biosystems Inc
F:3T2
|
US |
|
T
|
Trillium Gold Mines Inc
F:0702
|
CA |
|
B
|
Bioelife Corp
OTC:LITH
|
US |
|
Yukon Metals Corp
OTC:YMMCF
|
CA |
|
B
|
B-Scada Inc
OTC:SCDA
|
US |
|
P
|
PMV Consumer Acquisition Corp
OTC:PMVCD
|
US |
|
K
|
Kinetic Group Inc
OTC:KNIT
|
US |
|
P
|
Pine Valley Mining Corp
OTC:PVMCF
|
CA |
|
HyPower Fuel Inc
OTC:HYPF
|
CA |
|
Medical Cannabis Payment Solutions
OTC:REFG
|
US |
|
S
|
STS Evermedia Corp
OTC:SEVM
|
US |
|
B
|
Banco BPM SpA
F:BPM
|
IT |
|
Lotus Pharmaceuticals Inc
OTC:LTUS
|
CN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3T2's stock price target?
Not Available
3T2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for T2 Biosystems Inc?
Projected CAGR
41%
41%
Over the last 10 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 41%.
